Sai Life Sciences IPO: Comprehensive Peer Comparison with Pharmaceuticals Companies
This peer comparison evaluates Sai Life Sciences IPO against key competitors like Divi's Laboratories Limited, Suven Pharmaceuticals Limited and Syngene International Limited. By analysing essential financial metrics such as EPS, ROCE, ROE, P/E ratio, P/Bv, and Debt/Equity, investors can gain insights into the relative performance and valuation of these Pharmaceuticals companies. This comparison highlights the strengths and positioning of Sai Life Sciences in the competitive landscape of the Pharmaceuticals Industry.
Sai Life Sciences Limited IPO Peer Comparison |
|||||||||||
Company Name | EPS | ROCE | ROE | P/E (x) | P/Bv | Debt/Equity | RoNW (%) | ||||
Sai Life Sciences Limited | ₹0.40 | 10.26% | 8.49% | 136.21 | 5.74 | 0.75 | 8.50% | ||||
Divis Laboratories Limited | ₹69.2 | 16.5% | 12.2% | 88.6 | 11.9 | 0.00 | 12.2% | ||||
Suven Pharmaceuticals Limited | ₹9.55 | 18.8% | 14.1% | 137 | 16.8 | 0.02 | 14.1% | ||||
Syngene International Limited | ₹12.0 | 14.7% | 13.2% | 80.3 | 8.42 | 0.14 | 13.2% |
Stock Market Masterclass
FNO Stocks with CA Abhay
Equity Investment with CA Abhay
Equity Trading with CA Abhay
Option Trading with CA Abhay
Equity Trading with CA Abhay
Equity Investment with CA Abhay
Stock Market Masterclass
Option Trading with CA Abhay
FNO Stocks with CA Abhay
Copyright @2020 Design & Developed by Info Web Software